Clinical Trial Update: Maintenance Zanzalintinib With Etoposide After HDCT in GCT [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating maintenance zanzalintinib with etoposide after high-dose chemotherapy in germ cell tumors; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Germ Cell Tumor

Drugs mentioned

• Etoposide (Etoposide)
• Zanzalintinib (Zanzalintinib)

Snippet

Sponsor: Indiana University | Conditions: Germ Cell Tumor | Phase 1, Phase 2 | Status: RECRUITING